Additionally, based on the NGS results identifying the MLH1 mutation in one patient with cholangiocarcinoma, as well as other data supporting the incidence of a deficient mismatch repair (dMMR) phenotype in multiple GI cancers, we have routinely started screening all GI tumors for mismatch repair deficiency. The gene discussed is MLH1; the disease is digestive system neoplasm.